Organization
Les Laboratoires Servier SAS
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Les Laboratoires Servier SAS
... Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), and Servier, announced today that the pivotal Phase 3 (TAGS) trial evaluating LONSURF (trifluridine ...
... Taiho Pharmaceutical Co. Ltd. and Servier announced today that the pivotal Phase 3 (TAGS) trial evaluating LONSURF (trifluridine ...
... of our allogeneic CAR T-cells that were developed together with Pfizer and Servier,' said Andre Choulika, Chairman and Chief Executive Officer, Cellectis. 'Furthermore, we are ...
... Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), and Servier, announced today that the pivotal Phase 3 (TAGS) trial evaluating LONSURF®(trifluridine and ...
... of our allogeneic CAR T-cells that were developed together with Pfizer and Servier," said André Choulika, Chairman and Chief Executive Officer, Cellectis. "Furthermore, we are ...
... trial assessing its safety and tolerability following systemic dosing in collaboration with Servier, an independent international pharmaceutical company headquartered in France. 'We continue to be ...
... of a second Phase 1 clinical trial of MRG-110 in collaboration with Servier. MRG-110 is an inhibitor of microRNA-92. In preclinical studies, MRG-110 accelerated the ...
... trial assessing its safety and tolerability following systemic dosing in collaboration with Servier, an independent international pharmaceutical company headquartered in France. "We continue to be ...
... becoming a first-in-class disease-modifying drug as part of a collaboration agreement with Servier[1] signed in 2010. Galapagos has full US commercial rights to GLPG1972. Under ...
Subscribe now for full coverage on Les Laboratoires Servier SAS
Start My Free Trial